AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $1.72M invested in AIM ImmunoTech in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$15K
2
-$12K
3
-$6.15K
4
VKH
Virtu KCG Holdings
New York
-$6K
5
UBS Group
UBS Group
Switzerland
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$663K
2
$624K
3
$209K
4
$103K
5
$24K
6
$22K
7
$10K
8
$9K
9
$8K
10
$8K
11
$7K
12
$5K
13
$5K
14
$3K
15
$3K
16
$3K
17
$3K
18
$2K
19
$2K
20
$1.15K
21
$1K
22
$1K
23
–
24
–